(R)-Apremilast

CAS No. 608141-44-2

(R)-Apremilast( (R)-CC-10004 )

Catalog No. M26405 CAS No. 608141-44-2

(R)-Apremilast is the enantiomer of Apremilast and one of the isoindoline derivatives.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 78 In Stock
5MG 77 In Stock
10MG 117 In Stock
25MG 235 In Stock
50MG 346 In Stock
100MG 519 In Stock
200MG 728 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (R)-Apremilast
  • Note
    Research use only, not for human use.
  • Brief Description
    (R)-Apremilast is the enantiomer of Apremilast and one of the isoindoline derivatives.
  • Description
    (R)-Apremilast is the enantiomer of Apremilast and one of the isoindoline derivatives.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (R)-CC-10004
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    608141-44-2
  • Formula Weight
    460.5
  • Molecular Formula
    C22H24N2O7S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (217.16 mM)
  • SMILES
    CCOc1cc(ccc1OC)[C@H](CS(C)(=O)=O)N1C(=O)c2cccc(NC(C)=O)c2C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Baughman RG, Martin KL, Singh RK, Stoffer JO. 2,4-Dinitrophenylhydrazones of 2,4-dihydroxybenzaldehyde, 2,4-dihydroxyacetophenone and 2,4-dihydroxybenzophenone. Acta Crystallogr C. 2004 Feb;60(Pt 2):o103-6.
molnova catalog
related products
  • Dexamethasone 9,11-e...

    Dexamethasone 9,11-epoxide is a compound obtained by extraction and is an intermediate in the preparation of dexamethasone.

  • 20-Hydroxylucidenic ...

    20-Hydroxylucidenic acid E2 is a triterpenoid compound found in Ganoderma lucidum. It exhibits significant inhibitory effects on inflammation induced by TPA . Additionally, 20-Hydroxylucidenic acid E2 can suppress the expression of EBV early antigen induced by TPA , with a IC50 of 290 mol ratio/32 pmol TPA (meaning that when the molar concentration of this compound is 290 times that of 32 pmol of TPA, it can inhibit 50% of EBV early antigen expression). Therefore, 20-Hydroxylucidenic acid E2 has potential applications in anti-inflammatory and anticancer research.

  • H-Trp-Nle-Arg-Phe-NH...

    H-Trp-Nle-Arg-Phe-NH2